Pharmacology
News
Rheumatologic disease activity an important influencer of COVID-19 death risk
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from...
News
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)
Completed safety clinical trial shows occurrence of heart-related events and cancer in RA patients taking the Janus kinase inhibitor is higher...
News
Antidepressant may help COVID-19 patients avoid serious illness
Racetrack workers who developed COVID-19 and took a 2-week course of fluvoxamine did not have to be hospitalized and felt better after 2 weeks.
News
COVID-19: Another study links colchicine to better results
Brazilian trial tested gout drug against placebo in hospitalized patients.
Conference Coverage
Nivolumab improves survival in relapsed mesothelioma
Nivolumab prolonged progression-free and overall survival, compared with placebo.
Conference Coverage
‘Astonishing’ 4-year survival in NSCLC with pembro plus chemo
New data showing a doubling in survival with the combination versus chemo alone have been hailed as “very impressive” by clinicians.
News
Oral contraceptives may reduce ovarian and endometrial cancer risk 35 years after discontinuation
Women who take oral contraceptive pills may not have an increased lifetime risk of breast cancer, relative to women who have never taken them, a...
News
Aspirin linked to reduced bladder, breast cancer mortality
“The results presented here add to the accumulating evidence that aspirin may improve survival for some cancers.”
Conference Coverage
The jury’s still out on trifluridine/tipiracil plus bevacizumab in mCRC
Phase 3 results may provide more insight.
News
Naltrexone cuts hospitalization, deaths in alcohol use disorder
“Benzodiazepines should be avoided and not be administered other than for alcohol withdrawal symptoms,” Dr. Milja Heikkinen said.